Search icon

BIRED IMAGING, INC.

Company claim

Is this your business?

Get access!

Company Details

Name: BIRED IMAGING, INC.
Jurisdiction: New York
Legal type: FOREIGN BUSINESS CORPORATION
Status: Active
Date of registration: 03 Mar 2022 (3 years ago)
Entity Number: 6421499
ZIP code: 14618
County: Monroe
Place of Formation: Delaware
Foreign Legal Name: BIRED IMAGING, INC.
Address: 44 Brandywine Lane, ROCHESTER, NY, United States, 14618
Principal Address: 40 Franklin St., Rochester, NY, United States, 14604

DOS Process Agent

Name Role Address
SATISH KANDLIKAR, PRESIDENT, BIRED IMAGING, INC. DOS Process Agent 44 Brandywine Lane, ROCHESTER, NY, United States, 14618

Chief Executive Officer

Name Role Address
SATISH G KANDLIKAR Chief Executive Officer 44 BRANDYWINE LN, ROCHESTER, NY, United States, 14618

History

Start date End date Type Value
2022-03-04 2024-08-25 Address 44 brandywine lane, ROCHESTER, NY, 14618, USA (Type of address: Service of Process)

Filings

Filing Number Date Filed Type Effective Date
240825000063 2024-08-25 BIENNIAL STATEMENT 2024-08-25
220304000191 2022-03-03 APPLICATION OF AUTHORITY 2022-03-03

USAspending Awards / Financial Assistance

Date:
2025-01-21
Awarding Agency Name:
National Science Foundation
Transaction Description:
SBIR PHASE I: EFFICIENT THERMAL-SPATIAL POINT-CLOUD EXTRACTION AND RAPID ASSESSMENT OF PHYSICS-BASED AI ALGORITHM FROM INFRARED IMAGES TO INCREASE EARLY DETECTION OF BREAST CANCER -THE BROADER IMPACT/COMMERCIAL POTENTIAL OF THIS SMALL BUSINESS INNOVATION RESEARCH (SBIR) PHASE I PROJECT RELATES TO IMPROVING WOMEN?S HEALTH THROUGH EARLY DETECTION OF BREAST CANCER. WOMEN ABOVE AGE OF 40 YEARS ARE ADVISED TO UNDERGO ANNUAL/BIANNUAL SCREENING FOR BREAST CANCER. IN THE CURRENT BREAST CANCER SCREENING PARADIGM, MAMMOGRAPHY IS SUPPLEMENTED BY ADJUNCTIVE TECHNOLOGIES, SUCH AS ULTRASOUND IMAGING, TO IMPROVE THE CANCER DETECTION RATES. HOWEVER, SHORTCOMINGS FROM IMAGING DENSE BREAST TISSUE RELATING TO HIGHER PATIENT RECALL RATES FOR ADDITIONAL SCREENING AND LOWER DETECTION ACCURACY HAVE IMPACTED CONFIDENCE IN SCREENING. THIS SBIR PHASE I PROJECT AIMS TO IMPROVE EARLY CANCER DETECTION BY PROVIDING AN INNOVATIVE SCREENING TOOL THAT CAN ACCURATELY DETECT BREAST CANCER, EVEN IN DENSE BREASTS. THE INCREASE IN THE OVERALL DETECTION RATES AND IMPROVED CANCER DETECTION FROM THIS SCREENING TOOL IS EXPECTED TO PROVIDE SIGNIFICANT SHORT-TERM AND LONG-TERM SAVINGS IN HEALTHCARE COSTS. THIS TECHNOLOGY IS COST-EFFECTIVE AS IT DOES NOT REQUIRE SKILLED TECHNOLOGISTS SCREENING PATIENTS. IT WILL INCREASE THE REVENUE TO HOSPITALS/BREAST CLINICS WHILE PROVIDING MORE CONFIDENCE IN CANCER SCREENING AND SAVING OUT OF POCKET EXPENSE TO PATIENTS. THIS SMALL BUSINESS INNOVATION RESEARCH (SBIR) PHASE I PROJECT ADDRESSES A CRITICAL SOCIETAL NEED FOR ACCURATE BREAST CANCER DETECTION, ESPECIALLY IN WOMEN WITH DENSE BREASTS. MALIGNANT TUMORS GENERATE MORE HEAT AS COMPARED TO HEALTHY TISSUE DUE TO THEIR INCREASED METABOLIC ACTIVITY. IT CHANGES THE HEAT SIGNATURE ON THE SURFACE OF THE BREAST THAT CAN BE CAPTURED BY AN INFRARED CAMERA. THIS CONCEPT WAS UTILIZED TO DEVELOP A DEVICE THAT CAN EXTRACT THE SURFACE TEMPERATURES OF THE USING INFRARED IMAGING. A PHYSICS-BASED ARTIFICIAL INTELLIGENCE (AI) ALGORITHM THEN BACK-CALCULATES THE SIZE AND LOCATION OF A MALIGNANT TUMOR FROM THESE SURFACE TEMPERATURES. THE TECHNOLOGY IS FREE FROM HARMFUL RADIATIONS AND IS CONTACTLESS. TO MEET CURRENT CLINICAL WORKFLOW DEMANDS, IMPROVEMENTS IN IMAGING AND COMPUTING TIMES WILL BE PURSUED THROUGH TECHNICAL RESEARCH. FURTHER RESEARCH IN DATA GENERATION FROM IMAGING AND PHYSICS-BASED AI TECHNIQUES WILL BE CONDUCTED TO REDUCE THE IMAGING AND COMPUTING TIMES TO INTEGRATE THIS TECHNOLOGY INTO CLINICAL SETTINGS. AN INSTITUTIONAL REVIEW BOARD APPROVED CLINICAL STUDY WILL BE UNDERTAKEN TO VALIDATE THE METHODS DEVELOPED IN THIS PROJECT. THE OUTCOME FROM THIS PROJECT WILL BE A RAPID BREAST CANCER SCREENING TECHNOLOGY THAT WILL MEET CURRENT CLINICAL DEMANDS FOR EARLY DETECTION OF CANCER. THIS AWARD REFLECTS NSF'S STATUTORY MISSION AND HAS BEEN DEEMED WORTHY OF SUPPORT THROUGH EVALUATION USING THE FOUNDATION'S INTELLECTUAL MERIT AND BROADER IMPACTS REVIEW CRITERIA.- SUBAWARDS ARE NOT PLANNED FOR THIS AWARD.
Obligated Amount:
305000.00
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00
Date:
2021-12-28
Awarding Agency Name:
National Science Foundation
Transaction Description:
SBIR PHASE I: INNOVATIVE BREAST CANCER DETECTION ALGORITHM USING INFRARED IMAGES
Obligated Amount:
256000.00
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00

Trademarks Section

Serial Number:
90237463
Mark:
BIRED IMAGING
Status:
ABANDONED - NO STATEMENT OF USE FILED
Mark Type:
SERVICE MARK
Application Filing Date:
2020-10-06
Mark Drawing Type:
Standard character mark
Mark Literal Elements:
BIRED IMAGING

Goods And Services

For:
Medical services, namely, medical imaging services specializing in imaging of breast cancer; medical diagnosis of breast cancer; information, consultancy, and advisory services relating to all of the aforesaid services
International Classes:
044 - Primary Class
Class Status:
Active
Serial Number:
98563391
Mark:
BIRED IMAGING
Status:
Notice of Allowance (NOA) sent (issued) to the applicant. Applicant must file a Statement of Use or Extension Request within six months of the NOA issuance date.
Mark Type:
Service Mark
Application Filing Date:
2024-05-22
Mark Drawing Type:
4 - STANDARD CHARACTER MARK
Mark Literal Elements:
BIRED IMAGING

Goods And Services

For:
Medical services, namely, medical imaging services specializing in imaging of breast cancer; medical diagnosis of breast cancer; information, consultancy, and advisory services relating to all of the aforesaid services
International Classes:
044 - Primary Class
Class Status:
ACTIVE

Reviews Leave a review

This company hasn't received any reviews.

Date of last update: 21 Mar 2025

Sources: New York Secretary of State